Clinically Precedented Protein Kinases: Rationale for Their Use in Neurodegenerative Disease (2020)
Attributed to:
MICA: Evaluation of AZD1080 (GSK-3 inhibitor) in a preclinical mouse model of motor neuron disease (MND)
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3389/fnagi.2020.00242
Publication URI: http://dx.doi.org/10.3389/fnagi.2020.00242
Type: Journal Article/Review
Parent Publication: Frontiers in Aging Neuroscience